Differentiation between Brain Glioblastoma Multiforme and Solitary Metastasis: Qualitative and Quantitative Analysis Based on Routine MR Imaging

References

1. 1.↵
   1. Campos S,
   2. Davey P,
   3. Hird A,
   4. et al

   . Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma. Curr Oncol 2009;16:62–66

   PubMed
2. 2.↵
   1. Schwartz KM,
   2. Erickson BJ,
   3. Lucchinetti C.

   . Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology 2006;48:143–49

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Byrnes TJ,
   2. Barrick TR,
   3. Bell BA,
   4. et al

   . Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo. NMR Biomed 2011;24:54–60

   CrossRefPubMed
4. 4.↵
   1. Cha S,
   2. Knopp EA,
   3. Johnson G,
   4. et al

   . Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Tsuchiya K,
   2. Fujikawa A,
   3. Nakajima M,
   4. et al

   . Differentiation between solitary brain metastasis and high-grade glioma by diffusion tensor imaging. Br J Radiol 2005;78:533–37

   Abstract/FREE Full Text
6. 6.↵
   1. Cha S,
   2. Lupo JM,
   3. Chen MH,
   4. et al

   . Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078–84

   Abstract/FREE Full Text
7. 7.↵
   1. Toh CH,
   2. Wei KC,
   3. Ng SH,
   4. et al

   . Differentiation of brain abscesses from necrotic glioblastomas and cystic metastatic brain tumors with diffusion tensor imaging. AJNR Am J Neuroradiol 2011;32:1646–51

   Abstract/FREE Full Text
8. 8.↵
   1. Wang S,
   2. Kim S,
   3. Chawla S,
   4. et al

   . Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32:507–14

   Abstract/FREE Full Text
9. 9.↵
   1. Oh J,
   2. Cha S,
   3. Aiken AH,
   4. et al

   . Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging 2005;21:701–08

   CrossRefPubMed
10. 10.↵
    1. Lee EJ,
    2. terBrugge K,
    3. Mikulis D,
    4. et al

    . Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AJR Am J Roentgenol 2011;196:71–76

    CrossRefPubMed
11. 11.↵
    1. Lehmann P,
    2. Saliou G,
    3. de Marco G,
    4. et al

    . Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 2012;81:522–27

    CrossRefPubMed
12. 12.↵
    1. Blasel S,
    2. Jurcoane A,
    3. Franz K,
    4. et al

    . Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas. Acta Neurochir (Wien) 2010;152:1893–99

    CrossRefPubMed
13. 13.↵
    1. Server A,
    2. Orheim TE,
    3. Graff BA,
    4. et al

    . Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology 2011;53:319–30

    CrossRefPubMed
14. 14.↵
    1. Young GS,
    2. Setayesh K.

    . Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma. AJNR Am J Neuroradiol 2009;30:575–77

    Abstract/FREE Full Text
15. 15.↵
    1. Ma JH,
    2. Kim HS,
    3. Rim NJ,
    4. et al

    . Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. AJNR Am J Neuroradiol 2010;31:1699–706

    Abstract/FREE Full Text
16. 16.↵
    1. Calli C,
    2. Kitis O,
    3. Yunten N,
    4. et al

    . Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394–403

    CrossRefPubMed
17. 17.↵
    1. Opstad KS,
    2. Murphy MM,
    3. Wilkins PR,
    4. et al

    . Differentiation of metastases from high-grade gliomas using short echo time ¹H spectroscopy. J Magn Reson Imaging 2004;20:187–92

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Rousseau A,
    2. Mokhtari K,
    3. Duyckaerts C.

    . The 2007 WHO classification of tumors of the central nervous system–what has changed? Curr Opin Neurol 2008;21:720–27

    CrossRefPubMed
19. 19.↵
    1. Pereira-Filho Nde A,
    2. Soares FP,
    3. Chemale Ide M,
    4. et al

    . Peritumoral brain edema in intracranial meningiomas. Arq Neuropsiquiatr 2010;68:346–49

    CrossRefPubMed
20. 20.↵
    1. Mechtler L.

    . Neuroimaging in neuro-oncology. Neurotherapeutics 2009;27:171–201
21. 21.↵
    1. Cha S.

    . Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 2004;15:279–89

    CrossRefPubMed
22. 22.↵
    1. Machein MR,
    2. Plate KH.

    . VEGF in brain tumors. J Neurooncol 2000;50:109–20

    CrossRefPubMed
23. 23.↵
    1. Strugar J,
    2. Rothbart D,
    3. Harrington W,
    4. et al

    . Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 1994;81:560–66

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Chen X,
    2. Dai J,
    3. Jiang T.

    . Supratentorial WHO grade II glioma invasion: a morphologic study using sequential conventional MRI. Br J Neurosurg 2010;24:196–201

    CrossRefPubMed
25. 25.↵
    1. Chen XZ,
    2. Jiang T,
    3. Li SW,
    4. et al

    . Dynamic radiological change of gliomas located in the paralimbic system and its clinical significance. Chin Med J (Engl) 2008;121:713–15

    PubMed
26. 26.↵
    1. Duenisch P,
    2. Reichart R,
    3. Mueller U,
    4. et al

    . Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases. J Cancer Res Clin Oncol 2011;137:399–414

    CrossRefPubMed
27. 27.↵
    1. Kelly PJ,
    2. Daumas-Duport C,
    3. Scheithauer BE,
    4. et al

    . Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450–59

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Stummer W.

    . Mechanisms of tumor-related brain edema. Neurosurg Focus 2007;15:E8
29. 29.↵
    1. Engelhorn T,
    2. Savaskan NE,
    3. Schwarz MA,
    4. et al

    . Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci 2009;100:1856–62

    CrossRefPubMed